A new anti-melanoma drug:cobimetinib
ZHANG Ying;LIU Bo;HU Jin-cheng;ZHAO Jian-qi;Department of Pharmacy;the First Hospital of Jilin University;

..............page:2401-2404

Analysis of patent application situation of crizotinib
ZHOU Wen;Department of Pharmaceutical and Biological Invention Examination of the Patent Office;SIPO;

..............page:2405-2414

The angiotensin receptor-neprilysin inhibitor LCZ696
KUANG Ze-min;WANG Ying;WANG Jia-jie;YU Zhen-qiu;Department of Hypertension;Beijing Anzhen Hospital Affiliated to Capital Medical University;Department of Cardiology;Affiliated First People’s Hospital of Chenzhou;University of South China;Department of Cardiology;the Second Clinical Hospital Affiliated to University of South China;

..............page:2415-2420

Research on inspection technology for ophthalmic preparations after quality standard modification
SONG Fei;ZHAO Hong-ju;ZHAO Shuang-chun;WEI Jing;Business Administration College;Shenyang Pharmaceutical University;Liaoning Drug Certification Center;

..............page:2421-2425

Analysis of the quality control system suitable for nanomedicine in European
CHEN Kuan;Center for Medical Device Evaluation;China Food and Drug Administration;

..............page:2426-2429

Patent technology analysis for lenalidomide,a new immunomodulatory drug
HUANG Lu;LIU Zhe;XU Yong;Humanwell Healthcare Co.;Ltd.;Hubei Bio-pharmaceutical Industrial Technological Institute Inc.;

..............page:2430-2435

Reasearch progress and limitations of cardiac toxicity biomarkers
PAN Dong-sheng;ZHANG Ying-li;HUO Yan;WANG Ju-feng;LI Bo;National Center for Safety Evaluation of Drugs;National Institutes for Food and Drug Control;

..............page:2436-2440

Biochemical and immunological characteristics of group A and group C meningococcal polysaccharide-tetanus toxoid conjugates prepared by cyanogen bromide activation and amine reduction
ZHANG Na;WU Li-jie;ZHAO Jun;WANG Wei;CHI Jun;XIAO Zhan-rong;ZHANG Ping;Beijing Tiantan Biological Products Co.;Ltd.;

..............page:2441-2445

Current progress in research of radioactive nuclide decorporation
SONG Wei-jie;LU Xun;YANG Hui-yong;LEI Chun-hua;WANG Li-qiang;PLA 211 Hospital;School of Biomedical Sciences;Huaqiao University;Guangzhou Youmijian Pharmaceutical Technology Co.Ltd.;

..............page:2446-2449

Advances in studies on antibacterial activity and mechanism of anthraquinone compounds
DENG Li-hong;XIE Zhen;MAI Lan-yin;PANG Ting;CHEN Yong;TANG Yun-li;Faculty of Pharmacy;Guangxi University of Chinese Medicine;

..............page:2450-2455

Developments of circulating tumor DNA in clinical applications
DAI Wu-min;HAN Xiao-hong;SHI Yuan-kai;National Cancer Center/Cancer Hospital;Chinese Academy of Medical Sciences & Peking Union Medical College;

..............page:2456-2461

Immunogenicity analysis of monoclonal antibody drugs
SONG Wen-ya;SHI Yuan-kai;HAN Xiao-hong;National Cancer Center/Cancer Hospital;Chinese Academy of Medical Sciences and Peking Union Medical College;

..............page:2462-2465

Progress in research of drug resistance of non-small cell lung cancer to targeted therapy and the countermeasures
LIANG Cai-xia;SHI Yuan-kai;HAN Xiao-hong;National Cancer Center/Cancer Hospital;Chinese Academy of Medical Sciences & Peking Union Medical College;

..............page:2466-2472

Strategy of study design to non-clinical safety evaluation of paediatric medicines
SUN Zu-yue;ZHOU Li;Shanghai Institute of Planned Parenthood Research;National Evaluation Centre for Toxicology of Fertility Regulating Drugs;Key Laboratory of Reproduction Regulation of NPFPC;Reproductive and Developmental Research Institute of Fudan University;

..............page:2473-2482

Design on grouping of juvenile animal dosed prior to weaning during non-clinical safety evaluation
ZHOU Li;SUN Zu-yue;Shanghai Institute of Planned Parenthood Research;National Evaluation Centre for Toxicology of Fertility Regulating Drugs;Key Laboratory of Reproduction Regulation of NPFPC;Reproductive and Developmental Research Institute of Fudan University;

..............page:2483-2488

Pharmacokinetics of enteric-coated duloxetine hydrochloride tablets in Chinese healthy volunteers
WU Sha;WANG Shuang-shuang;HANG Tai-jun;SONG Min;Department of Pharmaceutical Analysis;China Pharmaceutical University;

..............page:2489-2494

Protective effect of DSPE-PEG-cholic acid modified silybin liposome on CCl₄-induced acute hepatic injury in mice
LI Ying;YANG Dan-dan;ZHANG Yun;ZHU Chun-yan;Institute of Medicinal Plant Development;Chinese Academy of Medical Sciences &Peking Union Medical College;

..............page:2495-2499

Preparation and characterization of furanodiene long-circulation liposomes
YANG Xiu-chun;ZHANG Jian-mei;LI Lin;WANG Dong-kai;Shenyang Pharmaceutical University;Ningxia Qiyuan Pharmaceutical Co.;Ltd.;

..............page:2500-2505

Experimental study of the genotoxicity of fresh Dendrobium
GU Fang-fang;ZHOU Xia-hui;ZHU Xiao-jing;CHEN Shan-shan;Wenzhou Central Hospital;

..............page:2506-2509

Determination of four free sugar components in intermediate product of Bozhi glycopeptide injection by HPLC-ELSD
DAI Dong-yan;XU Li;HUA Jie;Yangzhou Center for Food and Drug Control;Jiangsu Wande Environmental Technology Co.;Ltd.;

..............page:2510-2513

Analysis of influence factors on blood concentration monitoring of theophylline in our hospital
LIU Ze-hui;ZHANG Ya-tong;HU Xin;Department of Pharmacy Administration and Clinical Pharmacy;School of Pharmaceutical Sciences;Peking University;Beijing Hospital;National Center of Gerontology;

..............page:2514-2520